Source:http://linkedlifedata.com/resource/pubmed/id/19307019
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2010-8-24
|
pubmed:abstractText |
Leptospirosis is a worldwide zoonosis. Today, serological diagnosis is generally assessed by MAT. We performed ELISA with a synthetic peptide derived from Hap1/lipL32 which is a protein expressed only by pathogenic Leptospira. Repeatability and thresholds were defined with 85 controls sera and 119 hospitalized leptospirosis. The PP-ELISA repeatability and IgM/IgG cut-off values were based on control sera. For these cut-off values, we observed the IgM-PP-ELISA specificity of 89%, whereas it was 100% for the IgG. Then, we compared PP-ELISA and standard MAT results for leptospirosis patients. The concordance rate for IgM-PP-ELISA and MAT was low (43%), whereas it was 85% for IgG-PP-ELISA and MAT. During the first 5 days after hospitalization, PP-ELISA gave positive results in 13 out of 16 patients (81%) whereas 8 out of 14 patients (57%) were positive to MAT. ELISA using Hap1/lipL 32-derived synthetic peptide PP is an earlier serological diagnosis of human leptospirosis than MAT.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Bacterial,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Bacterial,
http://linkedlifedata.com/resource/pubmed/chemical/Bacterial Outer Membrane Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin G,
http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin M,
http://linkedlifedata.com/resource/pubmed/chemical/LipL32 protein, Leptospira,
http://linkedlifedata.com/resource/pubmed/chemical/Lipoproteins,
http://linkedlifedata.com/resource/pubmed/chemical/Peptides
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1878-1667
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright 2009 Elsevier Ltd. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
33
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
375-87
|
pubmed:meshHeading |
pubmed-meshheading:19307019-Antibodies, Bacterial,
pubmed-meshheading:19307019-Antigens, Bacterial,
pubmed-meshheading:19307019-Bacterial Outer Membrane Proteins,
pubmed-meshheading:19307019-Case-Control Studies,
pubmed-meshheading:19307019-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:19307019-Humans,
pubmed-meshheading:19307019-Immunoglobulin G,
pubmed-meshheading:19307019-Immunoglobulin M,
pubmed-meshheading:19307019-Leptospira,
pubmed-meshheading:19307019-Leptospirosis,
pubmed-meshheading:19307019-Lipoproteins,
pubmed-meshheading:19307019-Peptides,
pubmed-meshheading:19307019-Reproducibility of Results,
pubmed-meshheading:19307019-Serologic Tests
|
pubmed:year |
2010
|
pubmed:articleTitle |
Synthetic peptide issued from Hap1/LipL32 for new early serodiagnosis of human leptospirosis.
|
pubmed:affiliation |
Unité de Bactériologie Médicale et Moléculaire des Leptospires, Ecole Nationale Vétérinaire de Nantes, BP 40 706, 44 307 Nantes Cedex 03, France. florence_aviat@yahoo.fr
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|